This fundie shorted Polynovo (ASX:PNV) shares in 2019. Here’s how much he would have made

Was PolyNovo a good short idea?
The post This fundie shorted Polynovo (ASX:PNV) shares in 2019. Here’s how much he would have made appeared first on The Motley Fool Australia. –

The PolyNovo Ltd (ASX: PNV) share price has been well and truly out of form in 2021.

Since the start of the year, the medical device company’s shares have fallen a massive 63.5%.

This makes the PolyNovo share price one of the worst performers on the All Ordinaries this year.

Short seller delight

While shareholders will be very disappointed with PolyNovo share price performance this year, short sellers will be licking their lips.

At the last count, approximately 7.6% of the company’s shares were held by short sellers. These are investors that profit if the PolyNovo share price declines, rather than when it appreciates in value.

One of those short sellers could be Regal Funds Management. A touch over two years ago, the specialist alternatives investment manager’s Chief Investment Officer, Phil King, named PolyNovo as his top short idea at the 2019 conference.

On the day, 22 November 2019, the PolyNovo share price was trading at $1.92. Things didn’t get off to a great start for the pick, with the company’s shares soon rocketing higher after its NovoSorb BTM product was granted a certificate of conformance (CE Mark) approval for sale throughout UK/Ireland and the European Union.

In fact, before being caught up in the COVID-19 crash in February 2020, the PolyNovo share price had risen 61% since being picked to $3.09.

Things then get better for short sellers before they get worse…

It remains unknown whether Regal Funds held on during this time and wore the paper losses. If it did, it would have been pleased to see the company’s shares fall to $1.54 during the early stage of the COVID-induced market volatility in March 2020.

If the short seller closed their position at that point, it would have meant a return of 20% less carrying costs. Though, that is hardly an achievement given that if you went short on almost anything in February, you would have made huge returns in March after the market meltdown.

Unfortunately for any short sellers that didn’t sell at that point, the PolyNovo share price eventually found its legs and started its ascent soon after. It even managed to reach as high as $4.08 by December 2020. This is 112% higher than the price it was trading at when picked as a short around a year earlier.

All’s well that ends well

The good news for Regal Funds, if it is still shorting PolyNovo, is that this year has been horrendous for the company. Weaker than expected sales growth and the surprise exit of its CEO have all weighed heavily on the PolyNovo share price.

This has left it trading at $1.44 today, which is 25% lower than when nominated as a short pick. Though, after factoring in the carrying costs, one wonders whether it would have been worth all that volatility.

The post This fundie shorted Polynovo (ASX:PNV) shares in 2019. Here’s how much he would have made appeared first on The Motley Fool Australia.

Should you invest $1,000 in PolyNovo right now?

Before you consider PolyNovo, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and PolyNovo wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

Why Appen, Cooper Energy, PolyNovo, and Sigma shares are falling

These were the 5 worst performing ASX 200 shares in November

Here’s why the PolyNovo (ASX:PNV) share price is attracting increased short interest

These were the worst performing ASX 200 shares last week

Why did the Polynovo (ASX:PNV) share price just hit an 18-month low?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!